The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126974431 12697443 1 I 20160526 20160830 20160830 PER US-PFIZER INC-2016278462 PFIZER 73.00 YR F Y 80.29000 KG 20160830 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126974431 12697443 1 PS LYRICA PREGABALIN 1 Oral 50 MG, 1X/DAY (FOR TWO DAYS) Y N18481 21446 50 MG CAPSULE, HARD QD
126974431 12697443 2 SS LYRICA PREGABALIN 1 Oral 50 MG, 2X/DAY Y 21446 50 MG CAPSULE, HARD BID
126974431 12697443 3 SS NEURONTIN GABAPENTIN 1 UNK Y 20235
126974431 12697443 4 C TYLENOL EXTRA STRENGTH ACETAMINOPHEN 1 UNK 0
126974431 12697443 5 C NORVASC AMLODIPINE BESYLATE 1 UNK 0
126974431 12697443 6 C VIT B COMPLEX 2 UNK 0
126974431 12697443 7 C VITAMIN D3 CHOLECALCIFEROL 1 UNK 0
126974431 12697443 8 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 UNK 0
126974431 12697443 9 C DICYCLOMINE DICYCLOMINE HYDROCHLORIDE 1 UNK 0
126974431 12697443 10 C DOCUSATE CALCIUM. DOCUSATE CALCIUM 1 UNK 0
126974431 12697443 11 C LEVAQUIN LEVOFLOXACIN 1 UNK 0
126974431 12697443 12 C ATIVAN LORAZEPAM 1 UNK 0
126974431 12697443 13 C MESALAMINE. MESALAMINE 1 UNK 0
126974431 12697443 14 C MOMETASONE MOMETASONE 1 UNK 0
126974431 12697443 15 C GRAPE SEED EXTRACT GRAPE SEED EXTRACT 1 UNK 0
126974431 12697443 16 C OMEPRAZOLE. OMEPRAZOLE 1 UNK 0
126974431 12697443 17 C K-DUR POTASSIUM CHLORIDE 1 UNK 0
126974431 12697443 18 C XIFAXAN RIFAXIMIN 1 UNK 0
126974431 12697443 19 C REVATIO SILDENAFIL CITRATE 1 UNK 0
126974431 12697443 20 C DEMADEX TORSEMIDE 1 UNK 0
126974431 12697443 21 C TRAMADOL. TRAMADOL 1 UNK 0
126974431 12697443 22 C WARFARIN WARFARIN 1 UNK 0
126974431 12697443 23 C OPSUMIT MACITENTAN 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126974431 12697443 1 Neuropathy peripheral

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126974431 12697443 Bronchitis
126974431 12697443 Condition aggravated
126974431 12697443 Confusional state
126974431 12697443 Depression
126974431 12697443 Dizziness
126974431 12697443 Dyspnoea
126974431 12697443 Fall
126974431 12697443 Feeling abnormal
126974431 12697443 Gait disturbance
126974431 12697443 Intentional product use issue
126974431 12697443 Memory impairment
126974431 12697443 Pain in extremity
126974431 12697443 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126974431 12697443 2 20160523 0